Earth Science Tech ETST
OTC ETST
$0.09 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Earth Science Tech (ETST) Income from Non-Controlling Interests (2025 - 2026)

Earth Science Tech's (ETST) quarterly Income from Non-Controlling Interests came in at -$8495.0 in Q2 2026, down 2.04% on a YoY basis from -$8672.1 in Q2 2025, and down 1364.66% quarter-over-quarter from -$580.0 in Q1 2026.

Analysis

Earth Science Tech (ETST) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends

Earth Science Tech (ETST) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$8495.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Non-Controlling Interests fell 2.04% year-over-year to -$8495.0; the trailing twelve-month figure through Jun 2026 stood at -$30010.0 (changed N/A YoY), and the FY2026 full-year result was -$29839.0, changed N/A from the prior year.
  • Income from Non-Controlling Interests retreated to -$8495.0 in Q2 2026 per ETST's latest filing, from -$580.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$9.0 in Q4 2025 and bottomed at -$20926.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn -
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn -918,959.97
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn 11.95 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn 2.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn -
10 Earth Science Tech 25.88 Mn 23.09 Mn 6.28 Mn -8,495.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,495.00
Mar 31, 2026 -580.00
Dec 31, 2025 -9.00
Sep 30, 2025 -20,926.00
Jun 30, 2025 -8,325.00